Utility	O
of	O
dual	B:C4055114
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	O
iodine	O
contrast	I:C0879373
medium	I:C0879373
in	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
angiography	O
.	O

Utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	O
iodine	B:C0879373
contrast	I:C0879373
medium	I:C0879373
in	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
angiography	O
.	O

Utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	O
iodine	O
contrast	I:C0879373
medium	I:C0879373
in	O
deep	B:C2985549
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
angiography	O
.	O

Utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	O
iodine	O
contrast	I:C0879373
medium	I:C0879373
in	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
angiography	B:C0086305
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	B:C4055114
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	O
tomography	I:C4055114
)	O
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
(	O
CT	O
angiography	I:C1536105
)	O
of	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	B:C4055114
tomography	I:C4055114
)	O
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
(	O
CT	O
angiography	I:C1536105
)	O
of	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	O
tomography	I:C4055114
)	O
and	O
low	B:C3714384
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
(	O
CT	O
angiography	I:C1536105
)	O
of	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	O
tomography	I:C4055114
)	O
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	B:C1536105
angiography	I:C1536105
(	O
CT	O
angiography	I:C1536105
)	O
of	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	O
tomography	I:C4055114
)	O
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
(	O
CT	B:C1536105
angiography	I:C1536105
)	O
of	O
deep	O
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

To	O
evaluate	O
the	O
utility	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
computed	I:C4055114
tomography	I:C4055114
(	O
computed	O
tomography	I:C4055114
)	O
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
(	O
CT	O
angiography	I:C1536105
)	O
of	O
deep	B:C2985549
inferior	I:C2985549
epigastric	I:C2985549
perforator	I:C2985549
(	I:C2985549
DIEP	I:C2985549
)	I:C2985549
flaps	I:C2985549
.	O

In	O
this	O
prospective	B:C0033522
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	B:C1305855
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	B:C1536105
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	B:C2225488
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	B:C4055114
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	B:C0063757
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	B:C0879373
contrast	I:C0879373
agent	I:C0879373
iohexol	O
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

In	O
this	O
prospective	O
study	I:C0033522
,	O
40	O
patients	O
with	O
a	O
BMI	O
<	O
28.0	O
kg	O
/	O
m(	O
2	O
)	O
underwent	O
CT	O
angiography	I:C1536105
examination	O
for	O
breast	O
reconstruction	I:C2225488
and	O
were	O
randomly	O
assigned	O
into	O
two	O
groups	O
(	O
n=20	O
for	O
each	O
group	O
)	O
as	O
follows	O
:	O
Group	O
A	O
was	O
submitted	O
to	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
iodixanol	O
(	O
270	O
mg	O
I	O
/mL	O
)	O
and	O
Group	O
B	O
was	O
submitted	O
to	O
conventional	O
high	O
iodine	O
contrast	I:C0879373
agent	I:C0879373
iohexol	B:C0022005
(	O
350	O
mg	O
I	O
/mL	O
)	O
.	O

The	O
volume	O
CT	O
dose	O
index	O
(	O
CTDIvol	O
)	O
and	O
dose	O
length	O
product	O
were	O
recorded	O
and	O
the	O
effective	B:C0429197
dose	I:C0429197
(	O
effective	O
dose	I:C0429197
)	O
was	O
calculated	O
.	O

The	O
volume	O
CT	O
dose	O
index	O
(	O
CTDIvol	O
)	O
and	O
dose	O
length	O
product	O
were	O
recorded	O
and	O
the	O
effective	O
dose	I:C0429197
(	O
effective	B:C0429197
dose	I:C0429197
)	O
was	O
calculated	O
.	O

The	O
best	O
mono	B:C1704254
-	I:C1704254
spectrum	I:C1704254
images	I:C1704254
of	O
Group	O
A	O
were	O
selected	O
according	O
to	O
the	O
optimal	O
contrast	O
to	O
noise	O
ratio	O
(	O
CNR	O
)	O
.	O

Both	O
mono	B:C1704254
-	I:C1704254
spectrum	I:C1704254
images	I:C1704254
of	O
Group	O
A	O
and	O
polychromatic	O
images	I:C1704254
of	O
Group	O
B	O
were	O
used	O
to	O
reconstruct	O
maximum	O
intensity	O
projection	O
(	O
MIP	O
)	O
and	O
volume	O
rendering	O
(	O
VR	O
)	O
images	O
of	O
the	O
perforating	O
artery	I:C1181643
,	O
respectively	O
.	O

Both	O
mono	O
-	I:C1704254
spectrum	I:C1704254
images	I:C1704254
of	O
Group	O
A	O
and	O
polychromatic	B:C1704254
images	I:C1704254
of	O
Group	O
B	O
were	O
used	O
to	O
reconstruct	O
maximum	O
intensity	O
projection	O
(	O
MIP	O
)	O
and	O
volume	O
rendering	O
(	O
VR	O
)	O
images	O
of	O
the	O
perforating	O
artery	I:C1181643
,	O
respectively	O
.	O

Both	O
mono	O
-	I:C1704254
spectrum	I:C1704254
images	I:C1704254
of	O
Group	O
A	O
and	O
polychromatic	O
images	I:C1704254
of	O
Group	O
B	O
were	O
used	O
to	O
reconstruct	O
maximum	O
intensity	O
projection	O
(	O
MIP	O
)	O
and	O
volume	O
rendering	O
(	O
VR	O
)	O
images	B:C1704254
of	O
the	O
perforating	O
artery	I:C1181643
,	O
respectively	O
.	O

Both	O
mono	O
-	I:C1704254
spectrum	I:C1704254
images	I:C1704254
of	O
Group	O
A	O
and	O
polychromatic	O
images	I:C1704254
of	O
Group	O
B	O
were	O
used	O
to	O
reconstruct	O
maximum	O
intensity	O
projection	O
(	O
MIP	O
)	O
and	O
volume	O
rendering	O
(	O
VR	O
)	O
images	O
of	O
the	O
perforating	B:C1181643
artery	I:C1181643
,	O
respectively	O
.	O

Two	O
radiologists	B:C0260194
evaluated	O
subjective	O
image	O
quality	O
using	O
a	O
4	O
-	O
point	O
score	O
.	O

Two	O
radiologists	O
evaluated	O
subjective	B:C2266644
image	O
quality	O
using	O
a	O
4	O
-	O
point	O
score	O
.	O

The	O
diameter	O
of	O
the	O
perforating	B:C1181643
artery	I:C1181643
,	O
computed	O
tomography	I:C4055114
value	O
and	O
SD	O
value	O
for	O
the	O
common	O
femoral	O
artery	I:C0015801
were	O
measured	O
and	O
the	O
CNR	O
was	O
calculated	O
.	O

The	O
diameter	O
of	O
the	O
perforating	O
artery	I:C1181643
,	O
computed	B:C4055114
tomography	I:C4055114
value	O
and	O
SD	O
value	O
for	O
the	O
common	O
femoral	O
artery	I:C0015801
were	O
measured	O
and	O
the	O
CNR	O
was	O
calculated	O
.	O

The	O
diameter	O
of	O
the	O
perforating	O
artery	I:C1181643
,	O
computed	O
tomography	I:C4055114
value	O
and	O
SD	O
value	O
for	O
the	O
common	O
femoral	B:C0015801
artery	I:C0015801
were	O
measured	O
and	O
the	O
CNR	O
was	O
calculated	O
.	O

The	O
best	O
mono	O
-	O
spectrum	O
energy	O
with	O
the	O
optimal	O
CNR	O
of	O
the	O
perforating	B:C1181643
artery	I:C1181643
was	O
63	O
keV	O
.	O

The	O
computed	B:C4055114
tomography	I:C4055114
value	O
of	O
common	O
femoral	O
artery	I:C0015801
in	O
Group	O
A	O
(	O
380.96±42.75HU	O
)	O
was	O
7.40	O
%	O
higher	O
than	O
in	O
Group	O
B	O
(	O
354.71±42.01	O
HU	O
)	O
but	O
with	O
no	O
statistical	O
significance	O
(	O
P>.05	O
)	O
.	O

The	O
computed	O
tomography	I:C4055114
value	O
of	O
common	O
femoral	B:C0015801
artery	I:C0015801
in	O
Group	O
A	O
(	O
380.96±42.75HU	O
)	O
was	O
7.40	O
%	O
higher	O
than	O
in	O
Group	O
B	O
(	O
354.71±42.01	O
HU	O
)	O
but	O
with	O
no	O
statistical	O
significance	O
(	O
P>.05	O
)	O
.	O

The	O
CNR	O
of	O
the	O
common	O
femoral	B:C0015801
artery	I:C0015801
in	O
Group	O
A	O
(	O
23.84±6.73	O
)	O
was	O
6.88	O
%	O
lower	O
than	O
in	O
Group	O
B	O
(	O
25.60±6.20	O
)	O
,	O
with	O
no	O
significant	O
difference	O
(	O
P>.05	O
)	O
.	O

The	O
diameters	O
of	O
the	O
perforator	B:C0005847
vessels	I:C0005847
were	O
2.44±0.15	O
and	O
2.49±0.14	O
mm	O
,	O
respectively	O
,	O
with	O
no	O
significant	O
difference	O
(	O
P>.05	O
)	O
.	O

Subjective	B:C2266644
image	O
qualities	O
for	O
the	O
two	O
groups	O
were	O
both	O
good	O
for	O
diagnostics	O
,	O
and	O
the	O
scores	O
for	O
Group	O
A	O
and	O
Group	O
B	O
were	O
(	O
3.88±0.28	O
)	O
and	O
(	O
3.93±0.18	O
)	O
,	O
respectively	O
.	O

Subjective	O
image	O
qualities	O
for	O
the	O
two	O
groups	O
were	O
both	O
good	O
for	O
diagnostics	B:C0086141
,	O
and	O
the	O
scores	O
for	O
Group	O
A	O
and	O
Group	O
B	O
were	O
(	O
3.88±0.28	O
)	O
and	O
(	O
3.93±0.18	O
)	O
,	O
respectively	O
.	O

The	O
scores	O
of	O
the	O
two	O
radiologists	B:C0260194
were	O
consistent	O
(	O
kappa=0.634	O
)	O
.	O

The	O
combination	O
of	O
dual	B:C4055114
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
of	O
DIEP	O
flap	I:C2985549
examination	O
with	O
the	O
optimal	O
CNR	O
technology	O
can	O
meet	O
the	O
requirements	O
of	O
clinical	O
diagnostics	I:C0237512
,	O
with	O
a	O
22.86	O
%	O
reduction	O
in	O
total	O
iodine	O
intake	O
and	O
an	O
11.01	O
%	O
reduction	O
in	O
radiation	O
dose	O
.	O

The	O
combination	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	B:C3714384
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
of	O
DIEP	O
flap	I:C2985549
examination	O
with	O
the	O
optimal	O
CNR	O
technology	O
can	O
meet	O
the	O
requirements	O
of	O
clinical	O
diagnostics	I:C0237512
,	O
with	O
a	O
22.86	O
%	O
reduction	O
in	O
total	O
iodine	O
intake	O
and	O
an	O
11.01	O
%	O
reduction	O
in	O
radiation	O
dose	O
.	O

The	O
combination	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	B:C1536105
angiography	I:C1536105
of	O
DIEP	O
flap	I:C2985549
examination	O
with	O
the	O
optimal	O
CNR	O
technology	O
can	O
meet	O
the	O
requirements	O
of	O
clinical	O
diagnostics	I:C0237512
,	O
with	O
a	O
22.86	O
%	O
reduction	O
in	O
total	O
iodine	O
intake	O
and	O
an	O
11.01	O
%	O
reduction	O
in	O
radiation	O
dose	O
.	O

The	O
combination	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
of	O
DIEP	B:C2985549
flap	I:C2985549
examination	O
with	O
the	O
optimal	O
CNR	O
technology	O
can	O
meet	O
the	O
requirements	O
of	O
clinical	O
diagnostics	I:C0237512
,	O
with	O
a	O
22.86	O
%	O
reduction	O
in	O
total	O
iodine	O
intake	O
and	O
an	O
11.01	O
%	O
reduction	O
in	O
radiation	O
dose	O
.	O

The	O
combination	O
of	O
dual	O
-	I:C4055114
energy	I:C4055114
spectral	I:C4055114
CT	I:C4055114
and	O
low	O
-	I:C3714384
iodine	I:C3714384
intake	I:C3714384
in	O
CT	O
angiography	I:C1536105
of	O
DIEP	O
flap	I:C2985549
examination	O
with	O
the	O
optimal	O
CNR	O
technology	O
can	O
meet	O
the	O
requirements	O
of	O
clinical	B:C0237512
diagnostics	I:C0237512
,	O
with	O
a	O
22.86	O
%	O
reduction	O
in	O
total	O
iodine	O
intake	O
and	O
an	O
11.01	O
%	O
reduction	O
in	O
radiation	O
dose	O
.	O

